Glaxosmithkline Pharma Financials
NSE: GLAXO | BSE: 500660
₹2,957.80
₹-0.30
(-0.01%)
As on 07-Sep-2026IST
Market cap
₹50,093 Cr
Revenue (TTM)
₹3,955 Cr
P/E Ratio
46.9
P/B Ratio
19.9
Div. Yield
1.9 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,954.94
|
3,821.67
|
3,749.21
|
3,453.71
|
3,251.72
|
3,278.03
|
|
|
|
|
|
|
Total Income
|
4,100.34
|
3,967.03
|
3,895.14
|
3,576.30
|
3,352.38
|
3,353.80
|
|
|
|
|
|
|
Total Expenditure
|
2,601.44
|
2,512.47
|
2,571.85
|
2,545.02
|
2,447.44
|
2,516.15
|
|
|
|
|
|
|
EBITDA
|
1,353.50
|
1,309.20
|
1,177.36
|
908.69
|
804.29
|
761.88
|
|
|
|
|
|
|
Depreciation
|
66.76
|
66.44
|
66.79
|
69.68
|
65.77
|
68.19
|
|
|
|
|
|
|
EBIT
|
1,286.74
|
1,242.76
|
1,110.57
|
839.01
|
738.52
|
693.69
|
|
|
|
|
|
|
Interest
|
3.28
|
2.73
|
1.31
|
1.80
|
1.81
|
2.00
|
|
|
|
|
|
|
Other Income
|
145.40
|
145.36
|
145.93
|
122.59
|
100.66
|
75.78
|
|
|
|
|
|
|
Exceptional Items
|
20.62
|
20.63
|
4.69
|
-143.62
|
-0.97
|
11.58
|
|
|
|
|
|
|
Profit before Tax
|
1,449.48
|
1,406.01
|
1,259.88
|
816.19
|
836.40
|
779.05
|
|
|
|
|
|
|
Provision for Tax
|
381.33
|
370.03
|
332.30
|
226.23
|
228.76
|
398.28
|
|
|
|
|
|
|
Profit after Tax
|
1,068.15
|
1,035.98
|
927.58
|
589.96
|
607.64
|
380.77
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,068.15
|
1,035.98
|
927.58
|
589.96
|
610.69
|
1,694.72
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,267.42
|
2,267.42
|
1,951.31
|
1,777.64
|
1,741.27
|
2,662.96
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
277.34
|
143.50
|
110.73
|
107.72
|
125.40
|
158.75
|
|
|
|
|
|
|
Current Liabilities
|
1,779.11
|
1,779.10
|
1,905.15
|
1,524.95
|
1,326.37
|
1,698.43
|
|
|
|
|
|
|
Total Liabilities
|
4,323.87
|
4,323.87
|
4,108.07
|
3,556.62
|
3,326.58
|
4,633.28
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
416.63
|
583.82
|
557.32
|
611.89
|
698.77
|
812.10
|
|
|
|
|
|
|
Current Assets
|
3,606.18
|
3,606.20
|
3,409.88
|
2,798.42
|
2,494.26
|
3,707.92
|
|
|
|
|
|
|
Total Assets
|
4,323.87
|
4,323.87
|
4,108.07
|
3,556.62
|
3,326.58
|
4,633.28
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
1,827.07
|
1,827.09
|
1,504.73
|
1,273.47
|
1,167.89
|
2,009.49
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
515.18
|
456.22
|
387.33
|
353.87
|
354.78
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
903.30
|
1,289.90
|
582.02
|
484.23
|
810.75
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
396.98
|
-45.80
|
8.71
|
807.85
|
-405.51
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-737.08
|
-769.42
|
-561.50
|
-1,543.32
|
-524.24
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
563.20
|
474.68
|
29.23
|
-251.25
|
-119.00
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
62.15
|
61.15
|
54.76
|
34.83
|
36.05
|
100.04
|
|
|
|
|
|
|
Cash EPS (₹)
|
63.05
|
65.08
|
58.70
|
38.94
|
39.75
|
26.50
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
148.77
|
134.77
|
116.06
|
105.47
|
102.89
|
157.19
|
|
|
|
|
|
|
Dividend per Share (₹)
|
1.93
|
57.00
|
54.00
|
32.00
|
32.00
|
90.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
53.32
|
76.14
|
34.36
|
28.58
|
47.86
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
56.02
|
68.25
|
40.70
|
34.45
|
31.56
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
66.79
|
67.64
|
46.49
|
38.06
|
37.72
|
|
|
|
|
|
|
ROE (%)
|
52.98
|
48.76
|
49.43
|
33.43
|
27.58
|
18.39
|
|
|
|
|
|
|
ROA (%)
|
25.34
|
25.40
|
25.15
|
17.87
|
15.76
|
10.11
|
|
|
|
|
|
|
EBIT Margin (%)
|
32.54
|
32.52
|
29.62
|
24.29
|
22.71
|
21.16
|
|
|
|
|
|
|
Net Margin (%)
|
26.05
|
26.11
|
23.81
|
16.50
|
18.13
|
11.35
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
26.11
|
24.12
|
17.43
|
18.87
|
12.49
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.75
|
1.93
|
8.56
|
6.21
|
-0.80
|
12.05
|
|
|
|
|
|
|
EBIT Growth (%)
|
13.66
|
11.90
|
32.37
|
13.61
|
6.46
|
33.52
|
|
|
|
|
|
|
Net Profit Growth (%)
|
11.21
|
11.69
|
57.23
|
-2.91
|
59.58
|
32.55
|
|
|
|
|
|
|
EPS Growth (%)
|
12.41
|
11.69
|
57.23
|
-3.39
|
-63.97
|
373.19
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
16.12
|
10.05
|
2.51
|
-34.55
|
80.14
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
46.90
|
37.34
|
52.55
|
55.80
|
36.73
|
16.62
|
|
|
|
|
|
|
Price / Book Value
|
19.88
|
16.94
|
24.79
|
18.42
|
12.87
|
10.58
|
|
|
|
|
|
|
Dividend Yield (%)
|
1.93
|
2.50
|
1.88
|
1.65
|
2.42
|
5.41
|
|
|
|
|
|
|
EV/EBITDA
|
32.49
|
25.64
|
35.77
|
30.89
|
23.51
|
30.67
|
|
|
|
|
|
|
Close Price (₹)
|
2,450.30
|
2,283.00
|
2,880.35
|
1,946.60
|
1,324.75
|
1,666.90
|
|
|
|
|
|
|
High Price (₹)
|
3,450.05
|
3,515.95
|
3,088.00
|
2,649.95
|
1,684.80
|
1,918.75
|
|
|
|
|
|
|
Low Price (₹)
|
2,088.00
|
2,217.60
|
1,825.05
|
1,227.00
|
1,230.70
|
1,399.30
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
50,092.52
|
38,682.23
|
48,743.11
|
32,917.27
|
22,432.01
|
28,171.37
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
2.03
|
2.03
|
1.79
|
1.84
|
1.88
|
2.18
|
|
|
|
|
|
|
Quick Ratio
|
1.77
|
1.77
|
1.54
|
1.49
|
1.53
|
1.87
|
|
|
|
|
|
|
Interest Coverage
|
442.91
|
515.59
|
960.03
|
454.77
|
462.54
|
391.29
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
6.91
|
7.15
|
7.80
|
6.43
|
5.92
|
6.26
|
|
|
|
|
|
|
Asset Turnover
|
0.94
|
1.04
|
1.12
|
1.15
|
0.93
|
0.95
|
|
|
|
|
|
|
Receivable days
|
--
|
24.45
|
22.78
|
19.98
|
20.34
|
21.37
|
|
|
|
|
|
|
Inventory Days
|
--
|
40.60
|
44.57
|
47.50
|
50.87
|
54.91
|
|
|
|
|
|
|
Payable days
|
--
|
172.70
|
174.99
|
144.03
|
143.05
|
140.69
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-107.65
|
-107.65
|
-76.54
|
-71.84
|
-64.41
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
